2m 2m 2m 2m 2m 2m 2m
Premier Biomed (BIEI)
OTC
$0.001-$0.0002 (-15.38%)
Price as of Jun 24, 2026- $1.5MMarket Cap
- 69.23%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Premier Biomed (BIEI)
$0.001-$0.0002 (-15.38%)
BIEI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | -$0.0002 (-15.38%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 24,810,036 | ||
30-Day Average Volume | 25,650,299 | ||
1-Week Change | 0.00% | ||
1-Month Change | -26.67% | ||
1-Year Change | 69.23% | ||
3-Year Change | 57.14% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.4B | ||
Total Assets | $100,943.00 | ||
Market Cap | $1.5M | ||
Enterprise Value | $1.8M | ||
Period: QTR TTM FY | |||
Revenue | $1,306.00 | ||
Net Income | -$34,299.00 | ||
Free Cash Flow | -$71,012.00 | ||
EBIT | $256,457.00 | ||
EBITDA | $257,152.00 | ||
Net Working Capital | -$1.8M | ||
EPS | -$0.00 | ||
Enterprise Value/EBITDA | 7 | ||
Enterprise Value/Revenue | 1,370 | ||
P/B | -1 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 250 | ||
Last Split Date | 06/27/2018 | ||